CAS 191102-87-1

L-Leucine,N-[4-[(1H-imidazol-4-ylmethyl)amino]-2-(1-naphthalenyl)benzoyl]-,methyl ester

Description:

L-Leucine, N-[4-[(1H-imidazol-4-ylmethyl)amino]-2-(1-naphthalenyl)benzoyl]-, methyl ester, identified by CAS number 191102-87-1, is a synthetic compound that belongs to the class of amino acid derivatives. This substance features a leucine backbone, which is an essential branched-chain amino acid, modified with a naphthyl and imidazole moiety, contributing to its unique properties. The presence of the methyl ester group enhances its lipophilicity, potentially influencing its solubility and permeability in biological systems. The imidazole ring may impart biological activity, possibly interacting with various biological targets or pathways. This compound is of interest in medicinal chemistry and drug development, particularly for its potential applications in treating conditions related to protein synthesis or metabolic disorders. Its structural complexity suggests that it may exhibit specific pharmacological effects, although detailed studies would be necessary to elucidate its mechanism of action and therapeutic potential. As with many synthetic compounds, safety and toxicity assessments are crucial for determining its suitability for research or clinical use.

Formula: C₂₈H₃₀N₄O₃

GGTI 2147

CAS: 191102-87-1

GGTI 2147

Purity: ≥98%

Molecular weight: 470.56g/mol

Ref: 54-BUP03317

GGTI-2147

Controlled Product

CAS: 191102-87-1

Formula: C₂₈H₃₀N₄O₃

Color and Shape: Neat

Molecular weight: 470.563

Ref: TR-G368900

GGTI 2147

CAS: 191102-87-1

GGTI 2147 decreased Rac1 activity, down-regulated p65 expression, and ameliorated OGD/R-induced neuronal apoptosis.

Formula: C₂₈H₃₀N₄O₃

Purity: 98.69%

Color and Shape: Solid

Molecular weight: 470.56

Ref: TM-T25450